BMRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biomerica Inc (BMRA) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals. While technical indicators are neutral to slightly positive, the lack of strong momentum or institutional interest makes it a hold rather than a buy.
The MACD is slightly positive with a histogram of 0.0176, indicating mild bullish momentum. RSI is neutral at 59.192, and moving averages are converging, suggesting no clear trend. Key support is at 2.003, and resistance is at 2.209. Overall, the technical indicators are neutral to slightly positive but lack strong confirmation for a buy.
NULL. There are no significant news events, trading trends, or institutional interest to act as positive catalysts.
Gross margin also declined sharply by -84.24% YoY. The stock has no recent news or trading activity from insiders, hedge funds, or Congress, indicating a lack of interest or confidence.
In Q2 2026, revenue dropped to $1,210,000 (-26.04% YoY). Net income improved slightly to -$1,320,000 (+38.95% YoY), but the company is still operating at a loss. EPS increased to -0.45 (+2.27% YoY), but gross margin fell drastically to 4.21 (-84.24% YoY), indicating poor operational efficiency.
No recent analyst ratings or price target changes are available for BMRA.
